Menthol, Inflammation, and Nicotine Transition Study

Part of paid clinical trials in North Chicago, Illinois.

Sponsor
Rosalind Franklin University of Medicine and Science
Study ID
NCT06232447
Status
Recruiting
Apply to this trial

Conditions

  • Cigarette Smoking
  • Inflammatory Response

Eligibility Criteria

Sex
ALL
Age
21 Years - 85 Years
Healthy Volunteers
Accepted

Interventions

  • Cigarette Type Switching — OTHER
    Participants will be switched from smoking menthol cigarettes to non-menthol cigarettes for a period of four weeks

Study Details

This study will focus on examining the potential impact of menthol flavoring in cigarettes on biomarkers of systemic inflammation as a subclinical indicator of cardiovascular disease risk.

Key Dates

Start date
Mar 26, 2024
Status verified
Apr 2026
Primary completion
Jun 30, 2027
Completion
Jun 30, 2027

Study Design

Enrollment
68 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: Cigarette Type Switching
    Participants will be switched from smoking menthol cigarettes to non-menthol cigarettes

Primary Outcome Measure

high sensitivity C-reactive protein [ Time Frame: 4 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Rosalind Franklin University of Medicine and ScienceNorth ChicagoIllinois60064
Nancy C Jao, PhD
[email protected]
847-578-8747

Find similar trials in North Chicago, IL

By research site
Rosalind Franklin University of Medicine and Science· North Chicago, IL

Related Studies